ANDA 77058, held by Sun Pharm. Pantoprazole Sodium.
As of Nov 16, 2026, ANDA 77058 (Pantoprazole Sodium), held by Sun Pharm, was first approved by FDA on Sep 10, 2007, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 10, 2007 | Original application | Approved | None posted |
| Pantoprazole SodiumEQ 20MG BASE · tablet, delayed release;oral | Pantoprazole Sodium | Discontinued |
| Pantoprazole SodiumEQ 40MG BASE · tablet, delayed release;oral | Pantoprazole Sodium | Discontinued |
| Apr 8, 2015 | Supplement 16Labeling · Standard review | Approved | None posted |
| Dec 10, 2014 | Supplement 14Labeling · Standard review | Approved | None posted |
| Dec 10, 2014 | Supplement 12Labeling · Standard review | Approved | None posted |
| Apr 30, 2013 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jan 17, 2012 | Supplement 9Labeling | Approved | None posted |
| Jul 29, 2011 | Supplement 7Labeling | Approved | None posted |
| Jul 29, 2011 | Supplement 6Labeling | Approved | None posted |
| Aug 31, 2009 | Supplement 4Labeling | Approved | None posted |
| Sep 10, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters